Respiratory syncytial virus (RSV) (Fig. 1 ... There is no effective specific drug treatment for RSV and as a result, the mainstay of management for infants with RSV bronchiolitis is supportive ...

In a new cross-sectional analysis of 6,746 hospitalized adults aged 60 and older in 20 states, increased respiratory ...

1). Figure 1: The potential pool of patients who may seek respiratory syncytial virus (RSV) treatments. RSV particles offer several targets to developers of small-molecule drugs. Many of the ...

Interventions are needed to address barriers to respiratory syncytial virus protection among infants and pregnant individuals in the United States. A focused effort to ensure equitable and timely ...

Viruses including influenza, respiratory syncytial virus (RSV), many common cold viruses ... taking steps for cleaner air, treatment, and staying home and preventing spread. Additional strategies ...

"Val Kilmer had a history of throat cancer, but we don’t know if he was receiving recent treatment that ... COVID-19 and respiratory syncytial virus (RSV), according to Cleveland Clinic.

(NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for virology and immunology ...

Coinfection with RSV, REV, and MPV was significantly associated with treatment failure and prolonged treatment in children with viral LRTIs on respiratory support.

Knowledge of respiratory syncytial virus (RSV) disease and RSV vaccine eligibility is low among hospitalized older adults.

Enanta’s clinical programs are currently focused on respiratory syncytial virus (RSV) and its earlier-stage immunology pipeline aims to develop treatments for inflammatory diseases by targeting ...